10-K: Pioneer Green Farms Reports 2023 Financial Results, Cites Going Concern Uncertainty

Pioneer Green Farms' 2023 annual report reveals minimal revenue, a net loss, and substantial doubt about the company's ability to continue as a going concern without additional capital.

Summary

• Pioneer Green Farms, Inc. reported a net loss of $403,370 for the year ended December 31, 2023, compared to a net loss of $624,470 in 2022.
• The company generated $9,286 in revenue from CBD oil sales in 2023, a significant increase from no revenue in 2022.
• Cost of sales was $5,450 in 2023, compared to zero in 2022.
• Operating expenses decreased from $500,042 in 2022 to $394,569 in 2023, due to efficiencies in general and administrative costs and reduced labor expenses.
• Interest expense decreased significantly from $109,819 in 2022 to $12,654 in 2023 due to the expiration of debt discount amortization.
• The company's independent auditor has raised substantial doubt about its ability to continue as a going concern, citing minimal revenue and accumulated losses of $1,623,490 as of December 31, 2023.
• Pioneer Green Farms needs to raise additional capital by June 30, 2024, to fund operations beyond that date.
• The company had cash and equivalents of $627 as of December 31, 2023, compared to $11,532 in 2022, and outstanding debt of $1,136,777 compared to $943,223 in 2022.
• The company has a 25-year lease on a 5-acre orange grove and outbuildings, with a monthly rent of $1,000, and a management contract with the landowners for $6,500 per month plus 10% of gross sales.
• The company has a second location in Myakka City, Florida, purchased in January 2022, to increase crop output.

Sentiment

Score: 2

Explanation: The document highlights significant financial challenges, including a going concern warning from the auditor, minimal revenue, substantial losses, and the need for a capital raise. These factors indicate a very negative outlook from an investment perspective.

Positives

• The company generated revenue of $9,286 in 2023, a significant improvement from no revenue in 2022.
• The company reduced its net loss by $221,100 year-over-year.
• Operating expenses were reduced due to efficiencies and cost-cutting measures.
• Interest expenses decreased significantly due to the expiration of debt discount amortization.
• The company has two locations for growing hemp, which reduces risk and allows for year-round operations.

Negatives

• The company's auditor has expressed substantial doubt about its ability to continue as a going concern.
• The company has accumulated losses of $1,623,490 as of December 31, 2023.
• The company needs to raise additional capital by June 30, 2024, to fund operations.
• The company has minimal cash reserves of $627 as of December 31, 2023.
• The company has significant outstanding debt of $1,136,777 as of December 31, 2023.
• The company's stock is thinly traded on the OTC market.

Risks

• The company's ability to continue as a going concern is uncertain due to minimal revenue and accumulated losses.
• The company needs to raise additional capital by June 30, 2024, which may not be available on acceptable terms.
• The company operates in a highly competitive and regulated industry.
• The company's stock is thinly traded and subject to volatility.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company is subject to cybersecurity risks and the failure to maintain the integrity of data.
• The company lacks outside board directors, which could create conflicts of interest.
• The company does not have D&O insurance, which could expose directors and officers to financial risk.
• The company is subject to the SEC's penny stock rules, which may limit trading activity.

Future Outlook

The company anticipates that its principal sources of liquidity will only be sufficient to fund its activities and debt service needs through June 30, 2024. In order to have sufficient cash to fund its operations beyond June 30, 2024, the company will need to raise additional equity or debt capital by June 30, 2024 and increase sales, in order to continue as a going concern.

Management Comments

• Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses.
• Management intends to position itself so that it will be able to raise additional funds through the capital markets.

Industry Context

The document notes that the European CBD market is forecast to grow to 2.6 billion and the number of CBD users across the European continent is set to hit 50 million by 2026. The company is pursuing sales in the international markets of the oil extracted in these harvests. The document also notes that the CBD market, combined with THC products, will create a total market of $45 billion for cannabinoids by 2024.

Comparison to Industry Standards

• The document states that there are no businesses that can demonstrate or claim a dominant market share of the growing CBD products market in the United States.
• The document notes that competition is limited to numerous brands with geocentric distribution footprints.
• The document states that there are no major pharmaceutical manufacturing companies marketing general purpose CBD products into the overall CBD market at this time, although the Company is expecting such an entry in the future.
• The document notes that competition also includes many small regional marketers/packagers of CBD oil containing products that have limited distribution and economic resources.

Legal Proceedings

• Two parties have filed an action against the Company for breach of contract for failure to make payment on promissory notes, that were entered into when the Company purchased the Myakka farm.
• The Company is working to resolve these matters, and do not expect that the cases will have a material adverse effect on our financial position or results of operations.

Related Party Transactions

• At December 31, 2023, and 2022, the Company owed $757,541 and $321,214 to related parties including companies controlled by the CEO.
• These amounts are non-interest bearing and due upon demand.
• At December 31, 2023, the Company had a receivable from a former related party of $5,400 listed as an Other current asset.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern uncertainty and need for additional capital.
• Employees may be impacted by potential financial instability and the need for cost-cutting measures.
• Customers may be affected by potential disruptions in the company's operations.
• Creditors face increased risk due to the company's high debt levels and uncertain future.

Next Steps

• The company needs to raise additional capital by June 30, 2024.
• The company intends to increase sales.
• The company intends to position itself so that it will be able to raise additional funds through the capital markets.
• The company will enhance its internal controls through additional software and other means as revenues permit.
• The company intends to create an audit committee comprised of independent directors when it becomes a listed company under SEC rules.

Key Dates

Keywords

hemp, CBD oil, cannabinoids, agriculture, financial results, going concern, capital raise, internal control, OTC market, debt, operating expenses, revenue, net loss